Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate.
Kumar
Swati
S
Kohlhoff
Stephan
S
Valencia
Gloria
G
Hammerschlag
Margaret R
MR
Sharma
Roopali
R
D000081:Acetamides / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D016984:Enterococcus faecium / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D000069349:Linezolid; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D047928:Premature Birth; D016896:Treatment Outcome; D020713:Vancomycin Resistance; D017287:Ventriculoperitoneal Shunt / Q000009:adverse effects
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid